Fatal, gold-induced pneumonitis

We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Rheumatology international 2003-07, Vol.23 (4), p.207-210
Hauptverfasser: SOLER, M. Jose, BARROSO, Encarnacion, ARANDA, F. Ignacio, ALONSO, Sergio, ROMERO, Santiago
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 210
container_issue 4
container_start_page 207
container_title Rheumatology international
container_volume 23
creator SOLER, M. Jose
BARROSO, Encarnacion
ARANDA, F. Ignacio
ALONSO, Sergio
ROMERO, Santiago
description We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and prompt discontinuation of the drug is emphasised.
doi_str_mv 10.1007/s00296-003-0293-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_884136251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2695617347</sourcerecordid><originalsourceid>FETCH-LOGICAL-c382t-4e63060c7a16d729b97133717b11f0b66f656dda2348044b7a7513ffdca923573</originalsourceid><addsrcrecordid>eNp1kE1LAzEQhoMotlZ_gBctijejM0k2H0cpVoWCFwVvIZvsypbtbt3sHvz3pnShJy-ZDDzzDvMQconwgADqMQIwIykAp-nDqTgiUxRcUZTwdUymgIpRnZ4JOYtxDamXEk7JBJnOJAozJddL17v6fv7d1oFWTRh8Eebbphg2bVP1VTwnJ6WrY3Ex1hn5XD5_LF7p6v3lbfG0op5r1lNRSA4SvHIog2ImNwo5V6hyxBJyKUuZyRAc40KDELlyKkNelsE7w3im-Izc7HO3XfszFLG363bomrTSai2QS5b4Gbn9D2LSpIsUF7so3FO-a2PsitJuu2rjul-LYHfe7N6bTd7szpsVaeZqTB7yTREOE6OoBNyNgIve1WXnGl_FAyeMFjrd_AfjvXEf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2695617347</pqid></control><display><type>article</type><title>Fatal, gold-induced pneumonitis</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>SOLER, M. Jose ; BARROSO, Encarnacion ; ARANDA, F. Ignacio ; ALONSO, Sergio ; ROMERO, Santiago</creator><creatorcontrib>SOLER, M. Jose ; BARROSO, Encarnacion ; ARANDA, F. Ignacio ; ALONSO, Sergio ; ROMERO, Santiago</creatorcontrib><description>We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and prompt discontinuation of the drug is emphasised.</description><identifier>ISSN: 0172-8172</identifier><identifier>EISSN: 1437-160X</identifier><identifier>DOI: 10.1007/s00296-003-0293-4</identifier><identifier>PMID: 12856149</identifier><language>eng</language><publisher>Berlin: Springer</publisher><subject>Aged ; Antirheumatic Agents - adverse effects ; Arthritis, Rheumatoid - drug therapy ; Biological and medical sciences ; Fatal Outcome ; Female ; Gold Sodium Thiomalate - adverse effects ; Humans ; Lung Diseases, Interstitial - chemically induced ; Medical sciences</subject><ispartof>Rheumatology international, 2003-07, Vol.23 (4), p.207-210</ispartof><rights>2003 INIST-CNRS</rights><rights>Springer-Verlag 2003.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c382t-4e63060c7a16d729b97133717b11f0b66f656dda2348044b7a7513ffdca923573</citedby><cites>FETCH-LOGICAL-c382t-4e63060c7a16d729b97133717b11f0b66f656dda2348044b7a7513ffdca923573</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14984871$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12856149$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SOLER, M. Jose</creatorcontrib><creatorcontrib>BARROSO, Encarnacion</creatorcontrib><creatorcontrib>ARANDA, F. Ignacio</creatorcontrib><creatorcontrib>ALONSO, Sergio</creatorcontrib><creatorcontrib>ROMERO, Santiago</creatorcontrib><title>Fatal, gold-induced pneumonitis</title><title>Rheumatology international</title><addtitle>Rheumatol Int</addtitle><description>We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and prompt discontinuation of the drug is emphasised.</description><subject>Aged</subject><subject>Antirheumatic Agents - adverse effects</subject><subject>Arthritis, Rheumatoid - drug therapy</subject><subject>Biological and medical sciences</subject><subject>Fatal Outcome</subject><subject>Female</subject><subject>Gold Sodium Thiomalate - adverse effects</subject><subject>Humans</subject><subject>Lung Diseases, Interstitial - chemically induced</subject><subject>Medical sciences</subject><issn>0172-8172</issn><issn>1437-160X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNp1kE1LAzEQhoMotlZ_gBctijejM0k2H0cpVoWCFwVvIZvsypbtbt3sHvz3pnShJy-ZDDzzDvMQconwgADqMQIwIykAp-nDqTgiUxRcUZTwdUymgIpRnZ4JOYtxDamXEk7JBJnOJAozJddL17v6fv7d1oFWTRh8Eebbphg2bVP1VTwnJ6WrY3Ex1hn5XD5_LF7p6v3lbfG0op5r1lNRSA4SvHIog2ImNwo5V6hyxBJyKUuZyRAc40KDELlyKkNelsE7w3im-Izc7HO3XfszFLG363bomrTSai2QS5b4Gbn9D2LSpIsUF7so3FO-a2PsitJuu2rjul-LYHfe7N6bTd7szpsVaeZqTB7yTREOE6OoBNyNgIve1WXnGl_FAyeMFjrd_AfjvXEf</recordid><startdate>20030701</startdate><enddate>20030701</enddate><creator>SOLER, M. Jose</creator><creator>BARROSO, Encarnacion</creator><creator>ARANDA, F. Ignacio</creator><creator>ALONSO, Sergio</creator><creator>ROMERO, Santiago</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope></search><sort><creationdate>20030701</creationdate><title>Fatal, gold-induced pneumonitis</title><author>SOLER, M. Jose ; BARROSO, Encarnacion ; ARANDA, F. Ignacio ; ALONSO, Sergio ; ROMERO, Santiago</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c382t-4e63060c7a16d729b97133717b11f0b66f656dda2348044b7a7513ffdca923573</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Aged</topic><topic>Antirheumatic Agents - adverse effects</topic><topic>Arthritis, Rheumatoid - drug therapy</topic><topic>Biological and medical sciences</topic><topic>Fatal Outcome</topic><topic>Female</topic><topic>Gold Sodium Thiomalate - adverse effects</topic><topic>Humans</topic><topic>Lung Diseases, Interstitial - chemically induced</topic><topic>Medical sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SOLER, M. Jose</creatorcontrib><creatorcontrib>BARROSO, Encarnacion</creatorcontrib><creatorcontrib>ARANDA, F. Ignacio</creatorcontrib><creatorcontrib>ALONSO, Sergio</creatorcontrib><creatorcontrib>ROMERO, Santiago</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health &amp; Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health &amp; Nursing</collection><jtitle>Rheumatology international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SOLER, M. Jose</au><au>BARROSO, Encarnacion</au><au>ARANDA, F. Ignacio</au><au>ALONSO, Sergio</au><au>ROMERO, Santiago</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Fatal, gold-induced pneumonitis</atitle><jtitle>Rheumatology international</jtitle><addtitle>Rheumatol Int</addtitle><date>2003-07-01</date><risdate>2003</risdate><volume>23</volume><issue>4</issue><spage>207</spage><epage>210</epage><pages>207-210</pages><issn>0172-8172</issn><eissn>1437-160X</eissn><abstract>We report in detail an experience with irreversible interstitial pneumonitis developed during gold sodium thiomalate therapy. Factors that could influence the unfavourable course of this adverse, usually reversible pharmacological reaction, are analysed, and the importance of early recognition and prompt discontinuation of the drug is emphasised.</abstract><cop>Berlin</cop><pub>Springer</pub><pmid>12856149</pmid><doi>10.1007/s00296-003-0293-4</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0172-8172
ispartof Rheumatology international, 2003-07, Vol.23 (4), p.207-210
issn 0172-8172
1437-160X
language eng
recordid cdi_proquest_journals_884136251
source MEDLINE; SpringerLink Journals
subjects Aged
Antirheumatic Agents - adverse effects
Arthritis, Rheumatoid - drug therapy
Biological and medical sciences
Fatal Outcome
Female
Gold Sodium Thiomalate - adverse effects
Humans
Lung Diseases, Interstitial - chemically induced
Medical sciences
title Fatal, gold-induced pneumonitis
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-15T05%3A29%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Fatal,%20gold-induced%20pneumonitis&rft.jtitle=Rheumatology%20international&rft.au=SOLER,%20M.%20Jose&rft.date=2003-07-01&rft.volume=23&rft.issue=4&rft.spage=207&rft.epage=210&rft.pages=207-210&rft.issn=0172-8172&rft.eissn=1437-160X&rft_id=info:doi/10.1007/s00296-003-0293-4&rft_dat=%3Cproquest_cross%3E2695617347%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2695617347&rft_id=info:pmid/12856149&rfr_iscdi=true